Effect of Behavioral Therapy Versus Interferential Current on Bladder Dysfunction in Patients With Multiple Sclerosis
MS
1 other identifier
interventional
50
1 country
1
Brief Summary
study the effect of behavioral therapy and interferential current on management of bladder dysfunction in patients with multiple sclerosis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Feb 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 14, 2020
CompletedFirst Posted
Study publicly available on registry
November 19, 2020
CompletedNovember 19, 2020
November 1, 2020
1.1 years
November 14, 2020
November 14, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Detruser pressure between and within groups
test it by urodynamic test before and after management
eight weeks
Maximum flow rate between and within groups
test it by urodynamic test before and after management
eight weeks
Study Arms (2)
behavioral therapy
EXPERIMENTALapplying biofeedback training on the pelvic floor muscles
interferential therapy (IF)
EXPERIMENTALInterferential current was applied to the body using four surface electrodes placed on the lower abdomen and lower buttocks.
Interventions
compare the effect of applying both types of devices on the pelvic floor muscles
Eligibility Criteria
You may qualify if:
- All the patients were referred by a neurologist and the diagnosis was confirmed by the Magnetic Resonance Image (MRI).The duration of being diagnosed as SPMS for both groups were between one to two years. All the selected patients had normal mental examination according to mini mental scale .Also, all the selected patients were medically stable.
You may not qualify if:
- Patients with any other neurological deficits or orthopedics abnormalities or with auditory dysfunction were excluded from this study. Patients with history of bladder dysfunctions before the diagnosis of MS or attaining any attack during the treatment period were also excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taibah University
Madinah, 42353, Saudi Arabia
Study Officials
- PRINCIPAL INVESTIGATOR
walaa M Ragab, PHD
Taibah University ,saidi arab
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DR
Study Record Dates
First Submitted
November 14, 2020
First Posted
November 19, 2020
Study Start
February 15, 2019
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
November 19, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF